Skip to main content

Table 4 Characteristics of each group according to the management of anticoagulants

From: Clinical impact of the perioperative management of oral anticoagulants in bleeding after colonic endoscopic mucosal resection

 HBTa
(n = 14)
Continuous use of warfarin (n = 10)One-day skip of DOAC (n = 28)Control
(n = 643)
Age, mean ± SD, years61 ± 17.671.3 ± 11.569.6 ± 7.164.5 ± 11.0
Males/ Females, n11/ 37/ 321/ 7370/ 273
Using antiplatelets, n (%)4 (28.6)3 (30.0)6 (21.4)0
PT, mean ± SD, seconds14.8 ± 2.122.1 ± 4.4*, **12.9 ± 0.7412.6 ± 9.46
APTT, mean ± SD, seconds33.4 ± 4.3*37.6 ± 3.7*, ***34.2 ± 4.4*29.4 ± 4.5
Polyp, n3116621304
Pedunculated, n (%)3 (9.7)1 (6.3)5 (8.1)18 (1.4)
Size, mean ± SD, mm10.4 ± 7.08.2 ± 6.28.9 ± 5.69.5 ± 5.9
Prophylactic clip, n (%)21 (67.7)9 (56.3)34 (54.8)688 (52.8)
Procedure by expertb, n (%)10 (32.6)4 (25.0)10 (16.1)404 (31.0)
  1. aHBT heparin bridging therapy, bEndoscopist having experience more than10 years
  2. * v. s. Control, p < 0.05, ** v. s. DOAC p < 0.05, *** v. s. HBT p < 0.05